ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

QNCX Quince Therapeutics Inc

0.71
0.0121 (1.73%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 50,212
Bid Price 0.6303
Ask Price 0.72
News -
Day High 0.72

Low
0.6505

52 Week Range

High
1.70

Day Low 0.6979
Share Name Share Symbol Market Stock Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0121 1.73% 0.71 23:00:04
Open Price Low Price High Price Close Price Previous Close
0.70 0.6979 0.72 0.71 0.6979
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
328 50,212 US$ 0.705718 US$ 35,436 - 0.6505 - 1.70
Last Trade Type Quantity Price Currency
17:56:59 10 US$ 0.691 USD

Quince Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
83.59M 42.87M - 0 -31.39M -0.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Quince Therapeutics News

Date Time Source News Article
6/07/202420:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202420:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/07/202419:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/06/202416:17Edgar (US Regulatory)Form 8-K - Current report
6/05/202413:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/03/202406:00Business WireQuince Therapeutics Receives U.S. FDA Fast Track Designation..
5/13/202406:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202406:00Business WireQuince Therapeutics Provides Business Update and Reports..
5/06/202415:05Business WireQuince Therapeutics to Present at The Citizens JMP Life..
4/01/202406:00Business WireQuince Therapeutics Provides Business Update and Reports..
2/22/202406:00Business WireQuince Therapeutics Launches Scientific Advisory Board
2/15/202415:00Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No QNCX Message Board. Create One! See More Posts on QNCX Message Board See More Message Board Posts

Historical QNCX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.81910.81910.65050.741486192,985-0.1091-13.32%
1 Month0.910.970.65050.8230177146,635-0.20-21.98%
3 Months1.171.250.65050.9212331109,305-0.46-39.32%
6 Months0.961.43010.65051.0692,318-0.25-26.04%
1 Year1.551.700.65051.16141,678-0.84-54.19%
3 Years48.67121.980.540110.51613,605-47.96-98.54%
5 Years31.92121.980.540115.09431,579-31.21-97.78%

Quince Therapeutics Description

Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States.

Your Recent History

Delayed Upgrade Clock